A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain ...

A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...

Researchers cautioned that the existing evidence base is too poor to draw any solid conclusions on whether ketamine can help ...

The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

Ketamine is regularly used for the treatment of chronic pain, but a new report shows there is no clear evidence of its benefit.The off-label use of ...

Who is the ketamine queen that sold fatal drug, causing Matthew Perry death? Here's what to know about ketamine and why ...

Ketamine acts quickly in the body, and it is also cleared quickly, within hours. Yet Ryan and others who use it for chronic pain say the relief they get after their treatments lasts for months.

Tankha says he is hoping to raise enough money to properly study ketamine’s utility for chronic pain. “The binding to the receptor is over in maybe 10 to 15 minutes, maybe a couple hours, if ...

Ketamine acts quickly in the body, and it is also cleared quickly, within hours. Yet Ryan and others who use it for chronic pain say the relief they get after their treatments lasts for months.